Furthermore, a possible cooperation between the drug and arachidonic metabolisms in the pathogenesis of SCD has been highlighted, since some genes (for instance CYP2E1, CYP2C9, and CYP2J2) displaying variants with a statistical significance are involved in both metabolic processes (Supplementary Table S3). Here, CYP2C9 is linked to Schnyder corneal dystrophy.